Coherus BioSciences, Inc. announced it has entered into an agreement to divest its CIMERLI® ophthalmology franchise, inclusive of CIMERLI and its supporting commercial infrastructure, to Sandoz for upfront, all-cash consideration of $170 million plus an additional amount for CIMERLI product inventory and subject to customary working capital adjustments at the closing date.
Abivax SA, a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, provides an outlook on its 2024 strategic priorities and milestones.
Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months Read More »
Evotec SE is going to hold a conference call to provide a statement as well as a business update on Monday, 22 January 2024.
Evotec SE: Invitation to Conference Call – Jan 22, 2024 Read More »
Galderma announced it has received approval from Health Canada for Restylane® SHAYPE™, a hyaluronic acid injectable designed for temporary augmentation of the chin region.2 Engineered to build and shape on bone with deep injection for a bone-mimicking effect,1,2,3,4† Restylane® SHAYPE™ will be available in Canada as of February 2024.
ANGLE plc is pleased to announce the publication of a peer-reviewed paper in a special issue of the journal – “Current Issues in Molecular Biology” Special Issue: Advanced Solutions for Cancer Therapy.
Angle PLC Announces Potential Utility in Precision Oncology Read More »
Curasight A/S announced the achievement of the first milestone under the agreement with Curium inc., to develop Curasight’s uTRACE® PET imaging technology for the improved diagnosis of prostate cancer.
Curasight A/S Achieves First Milestone under collaboration with Curium Inc. Read More »
Existen tesoros cósmicos que nos narran historias fascinantes sobre la evolución del sistema solar y la posibilidad de vida más allá de la Tierra. Uno de estos tesoros es el meteorito Allan Hills 84001, una roca marciana que ha cautivado la atención de cientí …
Allan Hills 84001: El meteorito que vino de Marte Read More »
En ese rincón del sistema solar conocido como el cinturón de Kuiper, Plutón se alza como un objeto celeste especialmente importante. Aunque alguna vez fue considerado el noveno planeta, su estatus ha cambiado, pero su magnetismo científico sigue inalterado. Los estudios s …
La naturaleza despliega ocasionalmente espectáculos que desafían nuestra comprensión y despiertan la curiosidad científica. Uno de estos fenómenos intrigantes es el “Fuego de San Telmo”, un baile etéreo de luz que ha fascinado a marineros y cient&i …
InnoCare announced that tafasitamab in combination with lenalidomide has been recently approved by the Medical Products Administration of Guangdong Province, under the early access program in Guangdong-Hong Kong-Macao Greater Bay Area, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplant.
